Third quarter 2019 results

Tromsø, Norway, 24 October 2019 – Biotec Pharmacon (OSE: Biotec) announces its third quarter and first nine months 2019 results.

Highlights for Q3 2019 and the first nine months:

• Group sales marginally up from last year to NOK 22.5 million (Q3 2018: NOK 22.1 million).

• Gross profit for the Group improved 8% to NOK 15.7 million (Q3 2018: NOK 14.6 million) due to increased sales in the enzyme business.

• ArcticZymes had third quarter sales of NOK 12.0 million growing by 23% (Q3 2018: NOK 9.8 million).

• Woulgan® had lower than expected sales. Sales were NOK 1.1 million but shows growth compared to same quarter last year. Strategy to be reviewed by management and the Board of Directors.

• The Group delivered positive EBITDA with NOK 0.8 million (Q3 2018: NOK 0.6 million).

• Cash-flow for the quarter was NOK 0.7 million (Q3 2018: NOK -7.0 million).

 


Third quarter 2019 results

Second quarter 2019 results

First quarter 2019 results

Fourth quarter 2018 results

Third quarter 2018 results

Second quarter 2018 results

First quarter 2018 results

Fourth quarter 2017 results

Third quarter 2017 results

Second quarter 2017 results

First quarter 2017 results

Fourth quarter 2016 results

Third quarter 2016 results

Second quarter 2016 results

Presentation of the first quarter 2016

Presentation of the fourth quarter 2014

Presentation of the third quarter 2014

Presentation of the second quarter 2014

Presentation of the first quarter 2014

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the second quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter

Presentation of the first quarter

Presentation of the fourth quarter

Presentation of the third quarter